0 Comment
New York (EFE) Those elevated enzymes can often cause liver damage. However, the pharmaceutical giant said that no patients experienced “liver-related symptoms or side effects, there was no evidence of liver failure and none required treatment.” New York-based Pfizer said it will instead focus on its other oral obesity drug, danuglipron, which is in a... Read More